280 related articles for article (PubMed ID: 25779941)
1. Genomic landscape of human papillomavirus-associated cancers.
Rusan M; Li YY; Hammerman PS
Clin Cancer Res; 2015 May; 21(9):2009-19. PubMed ID: 25779941
[TBL] [Abstract][Full Text] [Related]
2. The landscape of viral associations in human cancers.
Zapatka M; Borozan I; Brewer DS; Iskar M; Grundhoff A; Alawi M; Desai N; Sültmann H; Moch H; ; Cooper CS; Eils R; Ferretti V; Lichter P;
Nat Genet; 2020 Mar; 52(3):320-330. PubMed ID: 32025001
[TBL] [Abstract][Full Text] [Related]
3. Transcriptionally active regions are the preferred targets for chromosomal HPV integration in cervical carcinogenesis.
Christiansen IK; Sandve GK; Schmitz M; Dürst M; Hovig E
PLoS One; 2015; 10(3):e0119566. PubMed ID: 25793388
[TBL] [Abstract][Full Text] [Related]
4. The pathology of HPV-related head and neck cancer: implications for the diagnostic pathologist.
Westra WH
Semin Diagn Pathol; 2015 Jan; 32(1):42-53. PubMed ID: 25804343
[TBL] [Abstract][Full Text] [Related]
5. Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data.
De Cecco L; Nicolau M; Giannoccaro M; Daidone MG; Bossi P; Locati L; Licitra L; Canevari S
Oncotarget; 2015 Apr; 6(11):9627-42. PubMed ID: 25821127
[TBL] [Abstract][Full Text] [Related]
6. NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome.
Chandrani P; Kulkarni V; Iyer P; Upadhyay P; Chaubal R; Das P; Mulherkar R; Singh R; Dutt A
Br J Cancer; 2015 Jun; 112(12):1958-65. PubMed ID: 25973533
[TBL] [Abstract][Full Text] [Related]
7. Quantitative DNA methylation analysis of candidate genes in cervical cancer.
Siegel EM; Riggs BM; Delmas AL; Koch A; Hakam A; Brown KD
PLoS One; 2015; 10(3):e0122495. PubMed ID: 25826459
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus and tonsillar and base of tongue cancer.
Ramqvist T; Grün N; Dalianis T
Viruses; 2015 Mar; 7(3):1332-43. PubMed ID: 25803099
[TBL] [Abstract][Full Text] [Related]
9. Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma.
Rocco JW
Head Neck Pathol; 2015 Mar; 9(1):1-5. PubMed ID: 25804377
[TBL] [Abstract][Full Text] [Related]
10. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.
Gaykalova DA; Manola JB; Ozawa H; Zizkova V; Morton K; Bishop JA; Sharma R; Zhang C; Michailidi C; Considine M; Tan M; Fertig EJ; Hennessey PT; Ahn J; Koch WM; Westra WH; Khan Z; Chung CH; Ochs MF; Califano JA
Int J Cancer; 2015 Oct; 137(8):1879-89. PubMed ID: 25857630
[TBL] [Abstract][Full Text] [Related]
11. Prevention of human papillomavirus-associated cancers.
Dillner J
Semin Oncol; 2015 Apr; 42(2):272-83. PubMed ID: 25843731
[TBL] [Abstract][Full Text] [Related]
12. Integration of the full-length HPV16 genome in cervical cancer and Caski and Siha cell lines and the possible ways of HPV integration.
Xu F; Cao M; Shi Q; Chen H; Wang Y; Li X
Virus Genes; 2015 Apr; 50(2):210-20. PubMed ID: 25823917
[TBL] [Abstract][Full Text] [Related]
13. Integrating genomics in head and neck cancer treatment: Promises and pitfalls.
Thariat J; Vignot S; Lapierre A; Falk AT; Guigay J; Van Obberghen-Schilling E; Milano G
Crit Rev Oncol Hematol; 2015 Sep; 95(3):397-406. PubMed ID: 25979769
[TBL] [Abstract][Full Text] [Related]
14. HPV positive oropharyngeal cancer and treatment deintensification: how pertinent is it?
Laskar SG; Swain M
J Cancer Res Ther; 2015; 11(1):6-9. PubMed ID: 25879328
[TBL] [Abstract][Full Text] [Related]
15. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a novel human papillomavirus-negative and radiosensitive head and neck squamous cell carcinoma cell line.
Kim KM; Park EJ; Yeo J; Joo YH; Cho KJ; Kim MS
Head Neck; 2016 Apr; 38 Suppl 1():E542-51. PubMed ID: 25784373
[TBL] [Abstract][Full Text] [Related]
17. Global Variation of Human Papillomavirus Genotypes and Selected Genes Involved in Cervical Malignancies.
Husain RS; Ramakrishnan V
Ann Glob Health; 2015; 81(5):675-83. PubMed ID: 27036725
[TBL] [Abstract][Full Text] [Related]
18. Recent Insights into the Control of Human Papillomavirus (HPV) Genome Stability, Loss, and Degradation.
Fisher C
J Clin Med; 2015; 4(2):204-30. PubMed ID: 25798290
[TBL] [Abstract][Full Text] [Related]
19. Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures.
Zhang Y; Koneva LA; Virani S; Arthur AE; Virani A; Hall PB; Warden CD; Carey TE; Chepeha DB; Prince ME; McHugh JB; Wolf GT; Rozek LS; Sartor MA
Clin Cancer Res; 2016 Sep; 22(18):4735-45. PubMed ID: 27091409
[TBL] [Abstract][Full Text] [Related]
20. Profiling invasiveness in head and neck cancer: recent contributions of genomic and transcriptomic approaches.
Nisa L; Aebersold DM; Giger R; Caversaccio MD; Borner U; Medová M; Zimmer Y
Cancers (Basel); 2015 Mar; 7(2):585-97. PubMed ID: 25836654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
